Viral vector

Microbiome-based therapies as anti-cancer agents

Read more

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

Read more

The race to develop a COVID-19 vaccine

Read more

Coronavirus pandemic ushers in new collaborations

Read more

Meeting the challenge of viral vector manufacture

Read more

Oxford BioMedica perfects lentiviral vectors for gene therapy

Read more